MetaCap

Who Owns BriaCell Therapeutics Stock?

NASDAQ: BCTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.95+0.035 (+0.89%)

Market open · Delayed 15 min · as of Oct 9, 1:49 PM ET

Ownership breakdown

Held by institutions
6.39%
Institutional holders
24
  • Institutions 6.4%
  • Insiders 0.0%
  • Public and other 93.6%

Who owns BriaCell Therapeutics stock?

Institutional investors own about 6.4% of BriaCell Therapeutics's shares, spread across 24 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.04% of BCTX.

The largest institutional holders are Cable Car Capital, LP (2.49%), Sabby Management, LLC (0.93%) and Iridian Asset Management LLC (0.75%). Together, the top 10 institutions control 5.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their BCTX positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of BCTX

BriaCell Therapeutics top institutional holders
InstitutionShares% HeldChange
Cable Car Capital, LP216.82K2.49%0.0%
Sabby Management, LLC80.72K0.93%+9.2%
Iridian Asset Management LLC65.00K0.75%0.0%
UBS Group AG43.64K0.50%+278.1%
HRT Financial LP34.90K0.40%+100.0%
Jane Street Group, LLC26.52K0.30%+100.0%
Luminarx Capital Management LP15.00K0.17%0.0%
National Bank of Canada/FI/1.80K0.02%+124.8%
Morgan Stanley1.03K0.01%-65.8%
Federation Des Caisses Desjardins Du Quebec4500.01%-1.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of BCTX

BriaCell Therapeutics top fund holders
FundShares% Held
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund3.23K0.04%

Frequently asked questions

Who is the largest shareholder of BriaCell Therapeutics?

Cable Car Capital, LP is the largest institutional shareholder of BCTX, owning 2.49% of shares outstanding (216.82K shares) as of its latest 13F filing.

What percentage of BriaCell Therapeutics is owned by institutions?

Institutions own about 6.4% of BCTX shares and 6.4% of the public float.

How much of BriaCell Therapeutics do insiders own?

Insiders, such as officers and directors, own about 0.04% of BCTX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related